Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
U01 (ssCART-19) in Relapsed or Refractory B-Cell Lymphoma
NCT06987916Phase 2Recruiting
- Sponsor
- Tongji Hospital
- Start
- Apr 2025
- Primary completion
- Apr 2028
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of ssCART-19 in B cell lymphoma, sponsored by Tongji Hospital. Started Apr 2025; status: recruiting.
02
Drugs
ssCART-19
03
Conditions
B cell lymphoma
Beyond the preview
Go deeper on NCT06987916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06987916.